Profilo
Jeffrey G.
Hesselberg is currently the Vice President-Regulatory & Quality Affairs at Castle Creek Biosciences, Inc. He previously worked as the Director-Regulatory Affairs at ICOS Corp.
from 1996 to 2007 and as the Vice President-Regulatory Affairs at GTx, Inc. He holds an MBA degree from the University of Washington and an undergraduate degree from the University of Wisconsin.
Posizioni attive di Jeffrey G. Hesselberg
| Società | Posizione | Inizio |
|---|---|---|
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Consigliere Generale | 01/01/2020 |
Precedenti posizioni note di Jeffrey G. Hesselberg
| Società | Posizione | Fine |
|---|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Consigliere Generale | 01/04/2007 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Consigliere Generale | - |
Formazione di Jeffrey G. Hesselberg
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
















